Akero Therapeutics, Inc. - COM (AKRO)

Historical Portfolio Holders from Q2 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
73M
Holdings value Q3 2024
$2.09B
Value change Q3 2024
+$38.7M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
166
Number of buys Q3 2024
77
Number of sells Q3 2024
-71
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 73M $2.09B +$38.7M $28.69 169
2024 Q2 71.8M $1.68B -$32.7M $23.46 151
2024 Q1 73M $1.84B +$364M $25.26 172
2023 Q4 58.4M $1.36B -$104M $23.35 156
2023 Q3 56.8M $2.87B +$69.1M $50.58 182
2023 Q2 56.4M $2.63B +$394M $46.69 156
2023 Q1 48.1M $1.84B -$63.9M $38.26 155
2022 Q4 48.5M $2.66B +$137M $54.80 159
2022 Q3 46.6M $1.59B +$489M $34.05 145
2022 Q2 34.9M $330M -$12.7M $9.45 108
2022 Q1 35.1M $499M -$2.94M $14.19 98
2021 Q4 35.3M $747M +$3.65M $21.15 96
2021 Q3 28M $626M +$7.1M $22.35 102
2021 Q2 27.6M $684M -$121M $24.81 94
2021 Q1 31.5M $914M +$20.1M $29.01 110
2020 Q4 30.8M $814M +$45.2M $25.80 94
2020 Q3 29M $892M +$220M $30.79 103
2020 Q2 21.8M $544M -$2.25M $24.92 75
2020 Q1 22M $467M +$63.2M $21.20 67
2019 Q4 19M $422M +$18.2M $22.19 57
2019 Q3 12.7M $288M +$54.8M $22.75 54
2019 Q2 10.7M $205M +$205M $19.15 48